Related Experiment Video

Updated: Jan 29, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.6K

Many ways to resistance: How melanoma cells evade targeted therapies

Ines Kozar1, Christiane Margue1, Sonja Rothengatter2

  • 1Life Sciences Research Unit, University of Luxembourg, 6, avenue du Swing, L-4367 Belvaux, Luxembourg.

Biochimica Et Biophysica Acta. Reviews on Cancer
|February 19, 2019
PubMed

Insights

Targeted therapies and immunotherapies improve melanoma survival but face resistance. Combining drugs targeting fast- and slow-proliferating cells may overcome this resistance and prevent tumor progression.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Research

Background:

  • Melanoma is an aggressive skin cancer originating from melanocytes.
  • Targeted therapies (MAPK pathway inhibitors) and immunotherapies (immune checkpoint inhibitors) have improved patient survival.
  • However, treatment efficacy is limited by side effects, lack of clinical effects, and emerging drug resistance.

Purpose of the Study:

  • To review current treatments for metastatic melanoma.
  • To summarize known resistance mechanisms to targeted therapies.
  • To focus on phenotype switching as a driver of drug resistance and explore novel approaches to circumvent it.

Main Methods:

  • Literature review of current treatment options for metastatic melanoma.
  • Analysis of molecular mechanisms underlying drug resistance.
  • Focus on phenotype switching and combination therapy strategies.

Main Results:

  • Phenotype switching is a key mechanism driving drug resistance in melanoma.
  • Combining drugs targeting fast- and slow-proliferating cells shows promise in controlling tumor progression.
  • Novel approaches are being developed to overcome treatment resistance.

Conclusions:

  • Phenotype switching significantly contributes to melanoma drug resistance.
  • Combination therapies targeting different cell proliferation rates may prevent or delay resistance.
  • Further research into combination strategies is crucial for improving long-term melanoma patient outcomes.

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.5K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.9K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K